US 8,563,273 B2 · Assignee: Tel Aviv University Future Technology Development L.P. · Inventors: Gazit; Ehud
Sheet 1 of 6 from the published document. All sheets in the USPTO PDF
This patent is listed from its USPTO record because it passed every check. Its abstract, claims and description are being downloaded from USPTO and will appear here within days. Until then, read it in the USPTO PDF or on Google Patents.
1 of 6 drawing sheets so far from the published document, cropped to the drawing. Every sheet is in the USPTO PDF.
The claims are being downloaded from USPTO and will appear here within days. Until then, read it in the USPTO PDF or on Google Patents.
The description is being downloaded from USPTO and will appear here within days. Until then, read it in the USPTO PDF or on Google Patents.
Fees are due 3.5, 7.5 and 11.5 years after grant. This patent expired on October 22, 2025, so the fee marked "not paid" was the one that went unpaid.
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
Filed Sep 2002 · published Mar 2004Peptides and methods using same for diagnosing and treating amyloid-associated diseases
Filed Jan 2007 · published Jun 2007Peptides and methods for inhibiting amyloid formation
Filed Apr 2009 · published Aug 2009Method of screening for compounds that disaggregate amyloid aggregates
Filed Apr 2009 · granted Oct 2013Earlier publications, parents and continuations. None of them can still be enforced, or this patent would not be listed.
No US citations on record.
Everything on this page comes from the documents linked above.